Geoepidemiology of systemic sclerosis

Autoimmunity Reviews

Volumn 9, Issue 5, 2010, Pages

  Ranque, Brigitte ^a   Mouthon, Luc ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Incidence; Mortality; Prevalence; Prognosis; Risk factors; Scleroderma, systemic

Indexed keywords

AUTOANTIBODY; SILICON DIOXIDE; SOLVENT;

AUSTRALIA; AWARENESS; CAUSE OF DEATH; CLINICAL FEATURE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; EPIDEMIC; EUROPE; GENDER; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; JAPAN; LUNG FIBROSIS; NORTH AMERICA; PREVALENCE; PROGNOSIS; PULMONARY HYPERTENSION; RARE DISEASE; RELIABILITY; REVIEW; RISK FACTOR; SKIN FIBROSIS; SURVIVAL; SYSTEMIC SCLEROSIS;

AUSTRALIA; EUROPE; FEMALE; HUMANS; INCIDENCE; JAPAN; NORTH AMERICA; PREVALENCE; RISK FACTORS; SCLERODERMA, SYSTEMIC;

EID: 77949272156     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.11.003     Document Type: Review

References (40)

1. Anon. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23 (1980) 581-590
2. LeRoy E.C., and Medsger Jr. T.A. Criteria for the classification of early systemic sclerosis. J Rheumatol 28 (2001) 1573-1576
3. Chandran G., Smith M., Ahern M.J., and Roberts-Thomson P.J. A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy. Aust NZ J Med 25 (1995) 688-694
4. Bernatsky S., Joseph L., Pineau C.A., Belisle P., Hudson M., and Clarke A.E. Scleroderma prevalence: demographic variations in a population-based sample. Arthritis Rheum 61 (2009) 400-404
5. Laing T.J., Gillespie B.W., Toth M.B., Mayes M.D., Gallavan Jr. R.H., Burns C.J., et al. Racial differences in scleroderma among women in Michigan. Arthritis Rheum 40 (1997) 734-742
6. Mayes M.D., Lacey Jr. J.V., Beebe-Dimmer J., Gillespie B.W., Cooper B., Laing T.J., et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48 (2003) 2246-2255
7. Le Guern V., Mahr A., Mouthon L., Jeanneret D., Carzon M., and Guillevin L. Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology (Oxford) 43 (2004) 1129-1137
8. Robinson Jr. D., Eisenberg D., Nietert P.J., Doyle M., Bala M., Paramore C., et al. Systemic sclerosis prevalence and comorbidities in the US, 2001-2002. Curr Med Res Opin 24 (2008) 1157-1166
9. Maricq H.R., Weinrich M.C., Keil J.E., Smith E.A., Harperl F.E., Nussbaum A.I., et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 32 (1989) 998-1006
10. Roberts-Thomson P.J., Jones M., Hakendorf P., Kencana Dharmapatni A.A., Walker J.G., MacFarlane J.G., et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Intern Med J 31 (2001) 220-229
11. Englert H., Small-McMahon J., Davis K., O'Connor H., Chambers P., and Brooks P. Systemic sclerosis prevalence and mortality in Sydney 1974-88. Aust NZ J Med 29 (1999) 42-50
12. Tamaki T., Mori S., and Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 283 (1991) 366-371
13. Silman A., Jannini S., Symmons D., and Bacon P. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 27 (1988) 286-290
14. Chifflot H., Fautrel B., Sordet C., Chatelus E., and Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37 (2008) 223-235
15. Czirjak L., Kiss C.G., Lovei C., Suto G., Varju C., Fuzesi Z., et al. Survey of Raynaud's phenomenon and systemic sclerosis based on a representative study of 10,000 south-Transdanubian Hungarian inhabitants. Clin Exp Rheumatol 23 (2005) 801-808
16. Arias-Nunez M.C., Llorca J., Vazquez-Rodriguez T.R., Gomez-Acebo I., Miranda-Filloy J.A., Martin J., et al. Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Medicine (Baltimore) 87 (2008) 272-280
17. Valesini G., Litta A., Bonavita M.S., Luan F.L., Purpura M., Mariani M., et al. Geographical clustering of scleroderma in a rural area in the province of Rome. Clin Exp Rheumatol 11 (1993) 41-47
18. Arnett F.C., Howard R.F., Tan F., Moulds J.M., Bias W.B., Durban E., et al. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum 39 (1996) 1362-1370
19. Thompson A.E., and Pope J.E. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J Rheumatol 29 (2002) 1867-1873
20. Englert H., Joyner E., Bade R., et al. Systemic scleroderma: a spatiotemporal clustering. Intern Med J 35 (2005) 228-233
21. Medsger Jr. T.A., Masi A.T., Rodnan G.P., Benedek T.G., and Robinson H. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 75 (1971) 369-376
22. Steen V.D., Oddis C.V., Conte C.G., Janoski J., Casterline G.Z., and Medsger Jr. T.A. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 40 (1997) 441-445
23. Roberts-Thomson P.J., Walker J.G., Lu T.Y., Esterman A., Hakendorf P., Smith M.D., et al. Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation. Intern Med J 36 (2006) 489-497
24. Nietert P.J., Mitchell H.C., Bolster M.B., Shaftman S.R., Tilley B.C., and Silver R.M. Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol 33 (2006) 263-268
25. Ferri C., Valentini G., Cozzi F., Sebastiani M., Michelassi C., La Montagna G., et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81 (2002) 139-153
26. Al-Dhaher F.F., Pope J.E., and Ouimet J.M. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum (2008)
27. Nietert P.J., and Silver R.M. Systemic sclerosis: environmental and occupational risk factors. Curr Opin Rheumatol 12 (2000) 520-526
28. Englert H., Small-McMahon J., Davis K., O'Connor H., Chambers P., and Brooks P. Male systemic sclerosis and occupational silica exposure-a population-based study. Aust NZ J Med 30 (2000) 215-220
29. Diot E., Lesire V., Guilmot J.L., Metzger M.D., Pilore R., Rogier S., et al. Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 59 (2002) 545-549
30. Walsh S.J. Effects of non-mining occupational silica exposure on proportional mortality from silicosis and systemic sclerosis. J Rheumatol 26 (1999) 2179-2185
31. Nietert P.J., Sutherland S.E., Silver R.M., Pandey J.P., Knapp R.G., Hoel D.G., et al. Is occupational organic solvent exposure a risk factor for scleroderma?. Arthritis Rheum 41 (1998) 1111-1118
32. Janowsky E.C., Kupper L.L., and Hulka B.S. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 342 (2000) 781-790
33. Arnett F.C., Cho M., Chatterjee S., Aguilar M.B., Reveille J.D., and Mayes M.D. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 44 (2001) 1359-1362
34. Feghali-Bostwick C., Medsger Jr. T.A., and Wright T.M. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 48 (2003) 1956-1963
35. Steen V.D., and Medsger T.A. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66 (2007) 940-944
36. Czirjak L., Kumanovics G., Varju C., Nagy Z., Pakozdi A., Szekanecz Z., et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 67 (2008) 59-63
37. Medsger Jr. T.A., and Masi A.T. Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 74 (1971) 714-721
38. Ioannidis J.P., Vlachoyiannopoulos P.G., Haidich A.B., Medsger Jr. T.A., Lucas M., Michet C.J., et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118 (2005) 2-10
39. Karassa F.B., and Ioannidis J.P. Mortality in systemic sclerosis. Clin Exp Rheumatol 26 (2008) S85-S93
40. Scussel-Lonzetti L., Joyal F., Raynauld J.P., Roussin A., Rich E., Goulet J.R., et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81 (2002) 154-167